Epigenetic Regulation in Overcoming Chemoresistance, Volume 19, explains how epigenetic agents can enhance the chemotherapy sensitivity of diverse types of cancers. The book provides a comprehensive delineation and the recent development of the scientific studies on the epigenetic regulation in enhancing chemo-sensitivity. In addition, it discusses several topics such as DNA methyltransferase inhibitors (DNMTi), Histone deacetylases inhibitors (HDACi), Histone lysine demethylases inhibitors (HDMi), Histone lysine methyltransferases inhibitors (HMTi) and drugs regulating the microRNA, long non-coding RNA (lncRNA) or RNA methylation. Finally, recent and future developments of the field of epigenetic regulation are explored.
This is a valuable resource for cancer researchers, clinicians, graduate students and several members of biomedical field who are interested in learning about epigenetic regulation methods to reverse chemo-resistance in cancers.
Produkteigenschaften
- Artikelnummer: 9780128236840
- Medium: Buch
- ISBN: 978-0-12-823684-0
- Verlag: Elsevier Health Sciences
- Erscheinungstermin: 25.06.2021
- Sprache(n): Englisch
- Auflage: Erscheinungsjahr 2021
- Produktform: Gebunden
- Gewicht: 450 g
- Seiten: 144
- Format (B x H): 191 x 235 mm
-
Ausgabetyp: Kein, Unbekannt